Background Neonatal jaundice is a transitional phenomenon affecting three out of five full-
term newborns globally. Ursodeoxycholic acid could be beneficial in neonatal jaundice …

Background Neonatal hyperbilirubinemia is observed in most newborns, and 5–15% of
neonates require phototherapy. Phototherapy is effective but often prolongs hospitalization …

Objectives Indirect hyperbilirubinemia during neonatal period is a common problem, and
most preterm and more than half of the term neonates find this problem. Ursodeoxycholic …

Background: This study was aimed at evaluating the effect of ursodeoxycholic acid (UDCA)
and multistrain synbiotic on indirect hyperbilirubinemia among neonates treated with …

Context: Hyperbilirubinemia is a common cause for diagnostic work-up and therapeutic
intervention in neonates and needs a convenient, quick, and safe treatment modality …

Aim This study aimed to investigate the effect of adding ursodeoxycholic acid (UDCA) to
phototherapy in neonates with glucose‐6‐phosphate dehydrogenase (G6PD) deficiency …

Introduction and aims Phototherapy is the most common treatment modality of neonatal
hyperbilirubinemia. We aimed to evaluate the therapeutic effect of oral Ursodeoxycholic Acid …

Exosomes are a subtype of natural extracellular vesicles that transfer a great number of
biomolecules, released by almost all types of cells, and can be specifically taken up by …

Glucose-6-phosphate dehydrogenase (G6PD) deficiency is one of the causes of severe
hyperbilirubinemia, prolonged jaundice, and bilirubin-induced encephalopathy in neonates …

Background: Exosomes are among the factors whose importance has been shown in many
diseases today. Recently, it has been shown that exosomes play an important role in the …